دورية أكاديمية

Mature T and NK cell lymphomas classified according to 2016 WHO classification. A report of 741 cases registered in the International Prospective T‐cell Project 2.0.

التفاصيل البيبلوغرافية
العنوان: Mature T and NK cell lymphomas classified according to 2016 WHO classification. A report of 741 cases registered in the International Prospective T‐cell Project 2.0.
المؤلفون: Manni, M., Chiattone, C. S., Prince, M. H., Pavlovsky, A., Tomuleasa, C., Miranda, E., Kriachok, I., Hawkes, E. A., Fiad, L., Hitz, F., Alpdogan, O., Nair, R., Advani, R., Minoia, C., Horwitz, S., Cabrera, M. E., Vose, J. M., Lymboussakis, A., Civallero, M., Skrypets, T.
المصدر: Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p311-312, 2p
مصطلحات موضوعية: KILLER cells, T cells, LYMPHOMAS, BONE marrow diseases, T-cell lymphoma
مستخلص: Mature T and NK cell lymphomas classified according to 2016 WHO classification. The T-cell Project 2.0 (TCP2) was launched in 2018 with the aim of better understanding this group of rare disorders, capturing a real-life snapshot of the evolving landscape of T-cell lymphoma biology, treatment strategies, and outcome. Overall, 88% were treated with combination chemotherapy and 28% of patients with advanced stage disease in complete or partial remission after chemotherapy were consolidated with high dose therapy and stem cell transplantation. [Extracted from the article]
Copyright of Hematological Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:02780232
DOI:10.1002/hon.3164_218